Related Experiment Video
Updated: Oct 5, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin
Hariharakrishnan Chidambaram1, Rashmi Das1, Subashchandrabose Chinnathambi1
1Neurobiology Group, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411008, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Abstract:
In Alzheimer's disease, the microtubule-associated protein, Tau misfolds to form aggregates and filaments in the intra- and extracellular region of neuronal cells. Microglial cells are the resident brain macrophage cells involved in constant surveillance and activated by the extracellular deposits. Purinergic receptors are involved in the chemotactic migration of microglial cells towards the site of inflammation. From our recent study, we have observed that the microglial P2Y12 receptor is involved in phagocytosis of full-length Tau species such as monomers, oligomers and aggregates by actin-driven chemotaxis. This study shows the interaction of repeat-domain of Tau (TauRD) with the microglial P2Y12 receptor and the corresponding residues for interaction have been analysed by various in-silico approaches. In the cellular studies, TauRD was found to interact with microglial P2Y12R and induces its cellular expression confirmed by co-immunoprecipitation and western blot analysis. Furthermore, the P2Y12R-mediated TauRD internalization has demonstrated activation of microglia with an increase in the Iba1 level, and TauRD becomes accumulated at the peri-nuclear region for the degradation. Similarly, immunofluorescence microscopic studies emphasized that TauRD is phagocytosed by microglial P2Y12R via the membrane-associated actin remodeling as filopodia extension. Upon internalization, we have demonstrated the P2Y12R signaling-mediated degradation of accumulated TauRD by lysosomal pathway. Altogether, microglial P2Y12R interacts with TauRD and mediates directed migration and activation for its internalization and degradation.
Insights
Microglial P2Y12 receptor binds Tau repeat-domain (TauRD), driving microglial migration and activation. This interaction facilitates TauRD internalization and lysosomal degradation, offering a novel therapeutic target for Alzheimer's disease.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Alzheimer's disease involves Tau protein misfolding and aggregation.
- Microglial cells, the brain's immune cells, respond to extracellular Tau deposits.
- Purinergic receptors mediate microglial migration to inflammatory sites.
Purpose of the Study:
- To investigate the interaction between the repeat-domain of Tau (TauRD) and the microglial P2Y12 receptor.
- To elucidate the role of P2Y12 receptor in TauRD internalization and degradation by microglia.
Main Methods:
- In-silico analysis to identify interaction residues between TauRD and P2Y12 receptor.
- Cellular studies including co-immunoprecipitation and western blot to confirm interaction and expression.
- Immunofluorescence microscopy to visualize TauRD phagocytosis and actin remodeling.
- Assessment of microglial activation markers (Iba1) and lysosomal pathway involvement.
Main Results:
- TauRD directly interacts with microglial P2Y12 receptor, confirmed by in-silico and cellular assays.
- P2Y12 receptor expression is upregulated upon TauRD interaction.
- TauRD internalization via P2Y12 receptor leads to microglial activation and accumulation of TauRD in the peri-nuclear region.
- Degradation of internalized TauRD occurs through the lysosomal pathway, mediated by P2Y12R signaling.
Conclusions:
- Microglial P2Y12 receptor plays a critical role in recognizing and internalizing TauRD.
- P2Y12 receptor signaling orchestrates microglial migration, activation, and subsequent degradation of TauRD.
- Targeting the microglial P2Y12 receptor presents a potential therapeutic strategy for Alzheimer's disease by enhancing Tau clearance.
Related Concept Videos
IP3/DAG Signaling Pathway
GPCR Desensitization
Activation and Inactivation of G Proteins
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors

